How to Buy Kalvista Pharmaceuticals Stock
Kalvista Pharmaceuticals Inc
KalVista Pharmaceuticals, Inc. , a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs.
Kalvista Pharmaceuticals stock last closed at $14.85, down 6.6% from the previous day, and has increased 71.68% in one year. It has overperformed other stocks in the Biotechnology industry by 1.13 percentage points. Kalvista Pharmaceuticals stock is currently +103.42% from its 52-week low of $7.30, and -14.16% from its 52-week high of $17.30.
As of Dec 17, 2025, there are 50.55M shares of KALV outstanding. The market value of KALV is $750.61M. In the last 24 hours, 1.22M KALV shares were traded.
How to Buy Kalvista Pharmaceuticals Stock
Not sure how to invest in Kalvista Pharmaceuticals stock? Here's how.
- Decide where to buy Kalvista Pharmaceuticals stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you figure out where to buy Kalvista Pharmaceuticals stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Choose your payment method and add your details.
- Research Kalvista Pharmaceuticals stock: The Kalvista Pharmaceuticals ticker symbol is KALV. Is Kalvista Pharmaceuticals stock a good investment? Should you buy shares of KALV? How do KALV's underlying business fundamentals look? Do top analysts think Kalvista Pharmaceuticals is a good buy? Why has KALV's stock price moved recently? (Hint: Our stock market research website can help you figure out if KALV is a good stock to buy).
- Execute your KALV purchase: Decide if you will purchase KALV shares at the current market price or use a limit order to purchase KALV shares at a particular price.
- Track your KALV position: Create a watchlist to important updates regarding your position in Kalvista Pharmaceuticals shares.
Step 1: Decide where to buy Kalvista Pharmaceuticals stock
You need a brokerage account in order to access the NASDAQ market and buy KALV shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global markets: From Tech to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the best brokerage, it's time to fill out some personal info so you are able to invest in KALV stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to open your new trading account.
- Submit your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have finished signing up on the best stock app, your next step is to transfer the money for your investment:
Check out the walkthrough below for more details transferring money into your new investment account.
Step 4: Research Kalvista Pharmaceuticals stock
Once you have figured out the best place to buy Kalvista Pharmaceuticals stock, it's very important to analyze their stock prior to buying, so you truly understand the risk as well as the upside.
Kalvista Pharmaceuticals quick stats
Fundamentals of KALV
WallStreetZen was designed to help everyday investors perform better fundamental analysis in less time.
You can see all of the due diligence checks on KALV's stock page.
Is KALV stock overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge KALV's intrinsic value.
Using relative valuations methods:
- KALV could be overvalued based on its P/B ratio of 44.16x, relative to Biotechnology industry P/B ratio of 5.19x
You can access additional valuation research on KALV's stock here.
KALV Financials at a glance
Pros:
- There are more short-term assets than long-term liabilities on the KALV balance sheet.
- There are more short-term assets than short-term liabilities on the KALV balance sheet.
Cons:
- KALV has a relatively high debt to equity ratio of 19.
- Total KALV debt is higher than 5 years ago, relative to shareholder equity.
Do Wall Street analysts think it's a good time to buy Kalvista Pharmaceuticals stock
Out of 4 sell side analysts who give recommendations on KALV, the consensus analyst rating on KALV is a Buy
Please note that analyst ratings are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Kalvista Pharmaceuticals stock forecast page.
KALV Momentum
Are KALV insiders buying or selling the stock?
Over the last year, insiders at KALV have bought more shares than they have sold.
Benjamin L. Palleiko, CHIEF EXECUTIVE OFFICER of KALV, was the latest KALV insider to sell. They sold $120,423.94 worth of KALV stock on Dec 8, 2025.
Dig into more about who owns KALV shares here.
Can I get consistent income from KALV stock?
No, Kalvista Pharmaceuticals doesn't provide an income stream by paying out dividends.
What others are saying about KALV
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your KALV purchase
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly fine. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a particular price, place a limit order.
Click the Open button and eToro will place the order.
If you want additional help with investing in stocks on eToro, click the helpful video below:
Step 6: Track your KALV position
Now that you own some KALV stock, you'll want to keep up with your investment.
Add KALV to a watchlist to monitor your KALV stock.
KALV Feed
How to Buy Stock in Kalvista Pharmaceuticals
To reiterate, here are the 6 steps for buying Kalvista Pharmaceuticals stock:
- Decide where to buy Kalvista Pharmaceuticals stock
- Create your brokerage account
- Deposit funds into your brokerage account
- Research Kalvista Pharmaceuticals stock
- Execute your KALV purchase
- Track your KALV position
If you are looking for a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you would like to watch your new investment in Kalvista Pharmaceuticals, create a watchlist on WallStreetZen today.
More Stock Buying Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.